Andrew Norris, MD, PhD
Division Director
Richard O. Jacobson Chair in Pediatric Endocrinology
Dr. Norris maintains a basic science laboratory focused on understanding the molecular and integrated physiology that contribute to diabetes pathogenesis. Dr. Norris has been continually funded as a principal investigator by the NIH since 2004. He serves as the Associate Director of the Fraternal Order of Eagles Diabetes Research Center, where he has helped develop a NIH T32-funded Diabetes Research Training Program. He publishes regularly in high impact journals.
A Rich Research History
The Division of Pediatric Endocrinology and Diabetes has a long and rich history of research aimed at bettering the lives of children. Seminal work in our Division dates back decades. For example, in 1946, our Division began publishing groundbreaking work indicating that better glucose control prevents complications in persons with type 1 diabetes. In the 1950s-2000s, Dr. Charlie Read led studies demonstrating the safety of radioiodine thyroid ablation for treatment of Graves disease and on how moderating carbohydrate intake can help improve diabetes control.
Our Ongoing Research Commitment
Our current faculty have carried on this passion to help find improved treatments and preventative strategies for endocrine disease. Our current research strengths include a focus on cystic fibrosis-related diabetes, Turner syndrome related diabetes, pancreatitis related diabetes, and clinical studies of type 1 and type 2 in youth. To read about our latest research updates and progress, please see the Director’s blog.
Research by Our Faculty
All of the faculty in the Division of Pediatric Endocrinology and Diabetes are involved in research. Several of our faculty are research focused, devoting significant portions of their professional time to research endeavors. However, impressively, even our clinically focused faculty continue to help drive important research progress in our field.
Dr. Alexandrou has published expertise in the areas of growth research, Turner Syndrome, and short stature.
Dr. Curtis has research interests in the areas of childhood growth and of metabolic fitness in children, having published in these areas.
Dr. Kanner has research interests focused on ovarian failure and polycystic ovarian syndrome in adolescents. She has published in this area.
Dr. Larson Ode's primary area of research interest is clinical and clinical-translational research into the pathophysiology of cystic fibrosis related diabetes mellitus, with additional interest in the pathophysiology of diabetes associated with pancreatitis in children.
Dr. Pesce has a long-standing interest in thyroid disorders, studying iodide transport under famed thyroid researcher Peter Kopp during her training. Since joining our faculty, she has continued this focus with ongoing clinical studies, and has published on thyroid cancer and newborn thyroid screening.
Dr. Pinnaro is a starting research-focused physician scientist, focused on clinicogenetic studies of endocrine modifiers in selected populations, including Turner syndrome. While a fellow, she published on the genetics of 22q syndrome and created a diabetes care simulation.
Dr. Ramakrishna has published expertise in the area of thyroid dysfunction, and has published on novel possible treatments for obesity.
Dr. Tansey has become established as a deep thinking and insightful clinical investigator focused on management and prevention of type 1 diabetes. He has participated in numerous NIH funded research endeavors and regularly publishes in leading diabetes journals.
Dr. Tsalikian is a seasoned diabetes investigator with an impressive research résumé. She started her faculty career at the University of Iowa, where she quickly obtained NIH funding for her investigations focused on intermediary metabolism. Over the ensuing years, she established herself as a leading investigator directing clinical studies related to diabetes, and has received numerous NIH grants. She has published nearly 100 research articles.